• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Sci Rep . Cytokine signatures of end organ injury in COVID-19

tetano

Editor, Senior Moderator
Sci Rep


. 2021 Jun 15;11(1):12606.
doi: 10.1038/s41598-021-91859-z.
Cytokine signatures of end organ injury in COVID-19


Luis G Gómez-Escobar[SUP] #[/SUP][SUP] 1 [/SUP], Katherine L Hoffman[SUP] #[/SUP][SUP] 2 [/SUP], Justin J Choi[SUP] 3 4 [/SUP], Alain Borczuk[SUP] 5 4 [/SUP], Steven Salvatore[SUP] 5 4 [/SUP], Sergio L Alvarez-Mulett[SUP] 1 [/SUP], Manuel D Galvan[SUP] 6 [/SUP], Zhen Zhao[SUP] 5 4 [/SUP], Sabrina E Racine-Brzostek[SUP] 5 4 [/SUP], He S Yang[SUP] 5 4 [/SUP], Heather W Stout-Delgado[SUP] 1 [/SUP], Mary E Choi[SUP] 7 4 [/SUP], Augustine M K Choi[SUP] 1 4 [/SUP], Soo Jung Cho[SUP] 8 9 [/SUP], Edward J Schenck[SUP] 10 11 [/SUP]



Affiliations

Abstract

Increasing evidence has shown that Coronavirus disease 19 (COVID-19) severity is driven by a dysregulated immunologic response. We aimed to assess the differences in inflammatory cytokines in COVID-19 patients compared to contemporaneously hospitalized controls and then analyze the relationship between these cytokines and the development of Acute Respiratory Distress Syndrome (ARDS), Acute Kidney Injury (AKI) and mortality. In this cohort study of hospitalized patients, done between March third, 2020 and April first, 2020 at a quaternary referral center in New York City we included adult hospitalized patients with COVID-19 and negative controls. Serum specimens were obtained on the first, second, and third hospital day and cytokines were measured by Luminex. Autopsies of nine cohort patients were examined. We identified 90 COVID-19 patients and 51 controls. Analysis of 48 inflammatory cytokines revealed upregulation of macrophage induced chemokines, T-cell related interleukines and stromal cell producing cytokines in COVID-19 patients compared to the controls. Moreover, distinctive cytokine signatures predicted the development of ARDS, AKI and mortality in COVID-19 patients. Specifically, macrophage-associated cytokines predicted ARDS, T cell immunity related cytokines predicted AKI and mortality was associated with cytokines of activated immune pathways, of which IL-13 was universally correlated with ARDS, AKI and mortality. Histopathological examination of the autopsies showed diffuse alveolar damage with significant mononuclear inflammatory cell infiltration. Additionally, the kidneys demonstrated glomerular sclerosis, tubulointerstitial lymphocyte infiltration and cortical and medullary atrophy. These patterns of cytokine expression offer insight into the pathogenesis of COVID-19 disease, its severity, and subsequent lung and kidney injury suggesting more targeted treatment strategies.
 
Back
Top Bottom